FDA approves ovarian cancer drug as treatment for advanced pancreatic cancer

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

A ray of hope for patients diagnosed with pancreatic cancer as an FDA-approved drug becomes approved for treatment of the disease.

Although Lynparza is not a new drug, a study found patients with pancreatic cancer who were treated could live nearly twice as long without their cancer worsening than those taking a placebo.

Pancreatic cancer is the third leading case of cancer deaths in the country. The pancreas is a small gland behind the stomach and in front of your spine. It produces digestive juices that help the body control blood sugar levels.

Tumors develop and aggressively spread in the early stages before patients develop symptoms which is why when pancreatic cancer is difficult to detect and once its diagnosed it’s often in the late stages.

About 50,000 Americans die each year from the disease.

Copyright 2022 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Connect with PIX11 Online

Connect with PIX11 Online

Trending Stories

Follow us on Facebook

Don't Miss

@PIX11News on Twitter